カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界の注射用エルタペネム市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Ertapenem for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO3229）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO3229
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の注射用エルタペネム市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

注射用エルタペネム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の注射用エルタペネムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

注射用エルタペネム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・純度 >98%、純度 >99%

用途別セグメントは次のように区分されます。
・静脈注射、筋肉注射

世界の注射用エルタペネム市場の主要な市場プレーヤーは以下のとおりです。
・Savior Lifetec Corporation、ACS Dobfar、Zhejiang Hisun Pharmaceutical、Sun Pharma、Zhejiang Hisoar、Kaliberr Labs、Qilu Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、注射用エルタペネム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な注射用エルタペネムメーカーの企業概要、2019年～2022年までの注射用エルタペネムの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な注射用エルタペネムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別注射用エルタペネムの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの注射用エルタペネムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での注射用エルタペネム市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および注射用エルタペネムの産業チェーンを掲載しています。
・第13、14、15章では、注射用エルタペネムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 注射用エルタペネムの概要
- 種類別分析（2017年vs2021年vs2028年）：純度 >98%、純度 >99%
- 用途別分析（2017年vs2021年vs2028年）：静脈注射、筋肉注射
- 世界の注射用エルタペネム市場規模・予測
- 世界の注射用エルタペネム生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Savior Lifetec Corporation、ACS Dobfar、Zhejiang Hisun Pharmaceutical、Sun Pharma、Zhejiang Hisoar、Kaliberr Labs、Qilu Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：純度 >98%、純度 >99%
・用途別分析2017年-2028年：静脈注射、筋肉注射
・注射用エルタペネムの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・注射用エルタペネムのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・注射用エルタペネムのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・注射用エルタペネムの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・注射用エルタペネムの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Ertapenem for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Ertapenem for Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Intravenous Injection accounting for % of the Ertapenem for Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Purity >98% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Ertapenem for Injection include Savior Lifetec Corporation, ACS Dobfar, Zhejiang Hisun Pharmaceutical, Sun Pharma, and Zhejiang Hisoar, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ertapenem for Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity >98%
Purity >99%
Market segment by Application can be divided into
Intravenous Injection
Intramuscular Injection
The key market players for global Ertapenem for Injection market are listed below:
Savior Lifetec Corporation
ACS Dobfar
Zhejiang Hisun Pharmaceutical
Sun Pharma
Zhejiang Hisoar
Kaliberr Labs
Qilu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ertapenem for Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ertapenem for Injection, with price, sales, revenue and global market share of Ertapenem for Injection from 2019 to 2022.
Chapter 3, the Ertapenem for Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ertapenem for Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Ertapenem for Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ertapenem for Injection.
Chapter 13, 14, and 15, to describe Ertapenem for Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Ertapenem for Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ertapenem for Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Purity >98%
1.2.3 Purity >99%
1.3 Market Analysis by Application
1.3.1 Overview: Global Ertapenem for Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Intravenous Injection
1.3.3 Intramuscular Injection
1.4 Global Ertapenem for Injection Market Size & Forecast
1.4.1 Global Ertapenem for Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Ertapenem for Injection Sales in Volume (2017-2028)
1.4.3 Global Ertapenem for Injection Price (2017-2028)
1.5 Global Ertapenem for Injection Production Capacity Analysis
1.5.1 Global Ertapenem for Injection Total Production Capacity (2017-2028)
1.5.2 Global Ertapenem for Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ertapenem for Injection Market Drivers
1.6.2 Ertapenem for Injection Market Restraints
1.6.3 Ertapenem for Injection Trends Analysis
2 Manufacturers Profiles
2.1 Savior Lifetec Corporation
2.1.1 Savior Lifetec Corporation Details
2.1.2 Savior Lifetec Corporation Major Business
2.1.3 Savior Lifetec Corporation Ertapenem for Injection Product and Services
2.1.4 Savior Lifetec Corporation Ertapenem for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 ACS Dobfar
2.2.1 ACS Dobfar Details
2.2.2 ACS Dobfar Major Business
2.2.3 ACS Dobfar Ertapenem for Injection Product and Services
2.2.4 ACS Dobfar Ertapenem for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Zhejiang Hisun Pharmaceutical
2.3.1 Zhejiang Hisun Pharmaceutical Details
2.3.2 Zhejiang Hisun Pharmaceutical Major Business
2.3.3 Zhejiang Hisun Pharmaceutical Ertapenem for Injection Product and Services
2.3.4 Zhejiang Hisun Pharmaceutical Ertapenem for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sun Pharma
2.4.1 Sun Pharma Details
2.4.2 Sun Pharma Major Business
2.4.3 Sun Pharma Ertapenem for Injection Product and Services
2.4.4 Sun Pharma Ertapenem for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zhejiang Hisoar
2.5.1 Zhejiang Hisoar Details
2.5.2 Zhejiang Hisoar Major Business
2.5.3 Zhejiang Hisoar Ertapenem for Injection Product and Services
2.5.4 Zhejiang Hisoar Ertapenem for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kaliberr Labs
2.6.1 Kaliberr Labs Details
2.6.2 Kaliberr Labs Major Business
2.6.3 Kaliberr Labs Ertapenem for Injection Product and Services
2.6.4 Kaliberr Labs Ertapenem for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Qilu Pharmaceutical
2.7.1 Qilu Pharmaceutical Details
2.7.2 Qilu Pharmaceutical Major Business
2.7.3 Qilu Pharmaceutical Ertapenem for Injection Product and Services
2.7.4 Qilu Pharmaceutical Ertapenem for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Ertapenem for Injection Breakdown Data by Manufacturer
3.1 Global Ertapenem for Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Ertapenem for Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Ertapenem for Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Ertapenem for Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Ertapenem for Injection Manufacturer Market Share in 2021
3.5 Global Ertapenem for Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Ertapenem for Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ertapenem for Injection Market Size by Region
4.1.1 Global Ertapenem for Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Ertapenem for Injection Revenue by Region (2017-2028)
4.2 North America Ertapenem for Injection Revenue (2017-2028)
4.3 Europe Ertapenem for Injection Revenue (2017-2028)
4.4 Asia-Pacific Ertapenem for Injection Revenue (2017-2028)
4.5 South America Ertapenem for Injection Revenue (2017-2028)
4.6 Middle East and Africa Ertapenem for Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Ertapenem for Injection Sales in Volume by Type (2017-2028)
5.2 Global Ertapenem for Injection Revenue by Type (2017-2028)
5.3 Global Ertapenem for Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Ertapenem for Injection Sales in Volume by Application (2017-2028)
6.2 Global Ertapenem for Injection Revenue by Application (2017-2028)
6.3 Global Ertapenem for Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Ertapenem for Injection Sales by Type (2017-2028)
7.2 North America Ertapenem for Injection Sales by Application (2017-2028)
7.3 North America Ertapenem for Injection Market Size by Country
7.3.1 North America Ertapenem for Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Ertapenem for Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Ertapenem for Injection Sales by Type (2017-2028)
8.2 Europe Ertapenem for Injection Sales by Application (2017-2028)
8.3 Europe Ertapenem for Injection Market Size by Country
8.3.1 Europe Ertapenem for Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Ertapenem for Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Ertapenem for Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Ertapenem for Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Ertapenem for Injection Market Size by Region
9.3.1 Asia-Pacific Ertapenem for Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Ertapenem for Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Ertapenem for Injection Sales by Type (2017-2028)
10.2 South America Ertapenem for Injection Sales by Application (2017-2028)
10.3 South America Ertapenem for Injection Market Size by Country
10.3.1 South America Ertapenem for Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Ertapenem for Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ertapenem for Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Ertapenem for Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Ertapenem for Injection Market Size by Country
11.3.1 Middle East & Africa Ertapenem for Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Ertapenem for Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Ertapenem for Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Ertapenem for Injection
12.3 Ertapenem for Injection Production Process
12.4 Ertapenem for Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Ertapenem for Injection Typical Distributors
13.3 Ertapenem for Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Ertapenem for Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Ertapenem for Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Savior Lifetec Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Savior Lifetec Corporation Major Business
Table 5. Savior Lifetec Corporation Ertapenem for Injection Product and Services
Table 6. Savior Lifetec Corporation Ertapenem for Injection Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. ACS Dobfar Basic Information, Manufacturing Base and Competitors
Table 8. ACS Dobfar Major Business
Table 9. ACS Dobfar Ertapenem for Injection Product and Services
Table 10. ACS Dobfar Ertapenem for Injection Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Zhejiang Hisun Pharmaceutical Major Business
Table 13. Zhejiang Hisun Pharmaceutical Ertapenem for Injection Product and Services
Table 14. Zhejiang Hisun Pharmaceutical Ertapenem for Injection Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharma Major Business
Table 17. Sun Pharma Ertapenem for Injection Product and Services
Table 18. Sun Pharma Ertapenem for Injection Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Zhejiang Hisoar Basic Information, Manufacturing Base and Competitors
Table 20. Zhejiang Hisoar Major Business
Table 21. Zhejiang Hisoar Ertapenem for Injection Product and Services
Table 22. Zhejiang Hisoar Ertapenem for Injection Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kaliberr Labs Basic Information, Manufacturing Base and Competitors
Table 24. Kaliberr Labs Major Business
Table 25. Kaliberr Labs Ertapenem for Injection Product and Services
Table 26. Kaliberr Labs Ertapenem for Injection Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Qilu Pharmaceutical Major Business
Table 29. Qilu Pharmaceutical Ertapenem for Injection Product and Services
Table 30. Qilu Pharmaceutical Ertapenem for Injection Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Ertapenem for Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Ton)
Table 32. Global Ertapenem for Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Ertapenem for Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Ertapenem for Injection Production Capacity by Company, (Ton): 2020 VS 2021
Table 35. Head Office and Ertapenem for Injection Production Site of Key Manufacturer
Table 36. Ertapenem for Injection New Entrant and Capacity Expansion Plans
Table 37. Ertapenem for Injection Mergers & Acquisitions in the Past Five Years
Table 38. Global Ertapenem for Injection Sales by Region (2017-2022) & (Ton)
Table 39. Global Ertapenem for Injection Sales by Region (2023-2028) & (Ton)
Table 40. Global Ertapenem for Injection Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Ertapenem for Injection Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Ertapenem for Injection Sales by Type (2017-2022) & (Ton)
Table 43. Global Ertapenem for Injection Sales by Type (2023-2028) & (Ton)
Table 44. Global Ertapenem for Injection Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Ertapenem for Injection Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Ertapenem for Injection Price by Type (2017-2022) & (US$/Ton)
Table 47. Global Ertapenem for Injection Price by Type (2023-2028) & (US$/Ton)
Table 48. Global Ertapenem for Injection Sales by Application (2017-2022) & (Ton)
Table 49. Global Ertapenem for Injection Sales by Application (2023-2028) & (Ton)
Table 50. Global Ertapenem for Injection Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Ertapenem for Injection Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Ertapenem for Injection Price by Application (2017-2022) & (US$/Ton)
Table 53. Global Ertapenem for Injection Price by Application (2023-2028) & (US$/Ton)
Table 54. North America Ertapenem for Injection Sales by Country (2017-2022) & (Ton)
Table 55. North America Ertapenem for Injection Sales by Country (2023-2028) & (Ton)
Table 56. North America Ertapenem for Injection Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Ertapenem for Injection Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Ertapenem for Injection Sales by Type (2017-2022) & (Ton)
Table 59. North America Ertapenem for Injection Sales by Type (2023-2028) & (Ton)
Table 60. North America Ertapenem for Injection Sales by Application (2017-2022) & (Ton)
Table 61. North America Ertapenem for Injection Sales by Application (2023-2028) & (Ton)
Table 62. Europe Ertapenem for Injection Sales by Country (2017-2022) & (Ton)
Table 63. Europe Ertapenem for Injection Sales by Country (2023-2028) & (Ton)
Table 64. Europe Ertapenem for Injection Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Ertapenem for Injection Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Ertapenem for Injection Sales by Type (2017-2022) & (Ton)
Table 67. Europe Ertapenem for Injection Sales by Type (2023-2028) & (Ton)
Table 68. Europe Ertapenem for Injection Sales by Application (2017-2022) & (Ton)
Table 69. Europe Ertapenem for Injection Sales by Application (2023-2028) & (Ton)
Table 70. Asia-Pacific Ertapenem for Injection Sales by Region (2017-2022) & (Ton)
Table 71. Asia-Pacific Ertapenem for Injection Sales by Region (2023-2028) & (Ton)
Table 72. Asia-Pacific Ertapenem for Injection Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Ertapenem for Injection Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Ertapenem for Injection Sales by Type (2017-2022) & (Ton)
Table 75. Asia-Pacific Ertapenem for Injection Sales by Type (2023-2028) & (Ton)
Table 76. Asia-Pacific Ertapenem for Injection Sales by Application (2017-2022) & (Ton)
Table 77. Asia-Pacific Ertapenem for Injection Sales by Application (2023-2028) & (Ton)
Table 78. South America Ertapenem for Injection Sales by Country (2017-2022) & (Ton)
Table 79. South America Ertapenem for Injection Sales by Country (2023-2028) & (Ton)
Table 80. South America Ertapenem for Injection Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Ertapenem for Injection Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Ertapenem for Injection Sales by Type (2017-2022) & (Ton)
Table 83. South America Ertapenem for Injection Sales by Type (2023-2028) & (Ton)
Table 84. South America Ertapenem for Injection Sales by Application (2017-2022) & (Ton)
Table 85. South America Ertapenem for Injection Sales by Application (2023-2028) & (Ton)
Table 86. Middle East & Africa Ertapenem for Injection Sales by Region (2017-2022) & (Ton)
Table 87. Middle East & Africa Ertapenem for Injection Sales by Region (2023-2028) & (Ton)
Table 88. Middle East & Africa Ertapenem for Injection Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Ertapenem for Injection Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Ertapenem for Injection Sales by Type (2017-2022) & (Ton)
Table 91. Middle East & Africa Ertapenem for Injection Sales by Type (2023-2028) & (Ton)
Table 92. Middle East & Africa Ertapenem for Injection Sales by Application (2017-2022) & (Ton)
Table 93. Middle East & Africa Ertapenem for Injection Sales by Application (2023-2028) & (Ton)
Table 94. Ertapenem for Injection Raw Material
Table 95. Key Manufacturers of Ertapenem for Injection Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Ertapenem for Injection Typical Distributors
Table 99. Ertapenem for Injection Typical Customers
List of Figures
Figure 1. Ertapenem for Injection Picture
Figure 2. Global Ertapenem for Injection Revenue Market Share by Type in 2021
Figure 3. Purity >98%
Figure 4. Purity >99%
Figure 5. Global Ertapenem for Injection Revenue Market Share by Application in 2021
Figure 6. Intravenous Injection
Figure 7. Intramuscular Injection
Figure 8. Global Ertapenem for Injection Revenue, (USD Million) & (Ton): 2017 & 2021 & 2028
Figure 9. Global Ertapenem for Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Ertapenem for Injection Sales (2017-2028) & (Ton)
Figure 11. Global Ertapenem for Injection Price (2017-2028) & (US$/Ton)
Figure 12. Global Ertapenem for Injection Production Capacity (2017-2028) & (Ton)
Figure 13. Global Ertapenem for Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Ertapenem for Injection Market Drivers
Figure 15. Ertapenem for Injection Market Restraints
Figure 16. Ertapenem for Injection Market Trends
Figure 17. Global Ertapenem for Injection Sales Market Share by Manufacturer in 2021
Figure 18. Global Ertapenem for Injection Revenue Market Share by Manufacturer in 2021
Figure 19. Ertapenem for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Ertapenem for Injection Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Ertapenem for Injection Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Ertapenem for Injection Sales Market Share by Region (2017-2028)
Figure 23. Global Ertapenem for Injection Revenue Market Share by Region (2017-2028)
Figure 24. North America Ertapenem for Injection Revenue (2017-2028) & (USD Million)
Figure 25. Europe Ertapenem for Injection Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Ertapenem for Injection Revenue (2017-2028) & (USD Million)
Figure 27. South America Ertapenem for Injection Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Ertapenem for Injection Revenue (2017-2028) & (USD Million)
Figure 29. Global Ertapenem for Injection Sales Market Share by Type (2017-2028)
Figure 30. Global Ertapenem for Injection Revenue Market Share by Type (2017-2028)
Figure 31. Global Ertapenem for Injection Price by Type (2017-2028) & (US$/Ton)
Figure 32. Global Ertapenem for Injection Sales Market Share by Application (2017-2028)
Figure 33. Global Ertapenem for Injection Revenue Market Share by Application (2017-2028)
Figure 34. Global Ertapenem for Injection Price by Application (2017-2028) & (US$/Ton)
Figure 35. North America Ertapenem for Injection Sales Market Share by Type (2017-2028)
Figure 36. North America Ertapenem for Injection Sales Market Share by Application (2017-2028)
Figure 37. North America Ertapenem for Injection Sales Market Share by Country (2017-2028)
Figure 38. North America Ertapenem for Injection Revenue Market Share by Country (2017-2028)
Figure 39. United States Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Ertapenem for Injection Sales Market Share by Type (2017-2028)
Figure 43. Europe Ertapenem for Injection Sales Market Share by Application (2017-2028)
Figure 44. Europe Ertapenem for Injection Sales Market Share by Country (2017-2028)
Figure 45. Europe Ertapenem for Injection Revenue Market Share by Country (2017-2028)
Figure 46. Germany Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Ertapenem for Injection Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Ertapenem for Injection Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Ertapenem for Injection Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Ertapenem for Injection Revenue Market Share by Region (2017-2028)
Figure 55. China Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Ertapenem for Injection Sales Market Share by Type (2017-2028)
Figure 62. South America Ertapenem for Injection Sales Market Share by Application (2017-2028)
Figure 63. South America Ertapenem for Injection Sales Market Share by Country (2017-2028)
Figure 64. South America Ertapenem for Injection Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Ertapenem for Injection Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Ertapenem for Injection Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Ertapenem for Injection Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Ertapenem for Injection Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Ertapenem for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Ertapenem for Injection in 2021
Figure 76. Manufacturing Process Analysis of Ertapenem for Injection
Figure 77. Ertapenem for Injection Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • エルタペネム側鎖のグローバル市場展望 2023年-2029年：純度98%以下、純度98%-99%、純度99%以上
  • 世界の漢方注射市場2022年：市場規模予測（～2028年）
  • 世界のカルバペネムAPI市場2022年：市場規模予測（～2028年）
  • 世界のフルマゼニル注射市場2022年：市場規模予測（～2028年）
  • 注射用カルバゾクロムスルホン酸ナトリウムのグローバル市場展望 2023年-2029年：20mg、40mg、60mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO3229 )"世界の注射用エルタペネム市場2022年：市場規模予測（～2028年）" (英文：Global Ertapenem for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。